About Shimonoseki City Hospital
地方独立行政法人下関市立市民病院は、山口県下関市向洋町にある病院。災害拠点病院及び地域医療支援病院に指定されている。
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Shimonoseki City Hospital
During the past decade, Shimonoseki City Hospital conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 3 clinical trials were completed, i.e. on
average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Safety and Tolerability Study of Claudiximab in Patients With Advanced Gastroesophageal Cancer
2009-05-01
2010-05-01
Completed
15
A Study of Obinutuzumab (RO5072759) Plus Chemotherapy in Comparison With Rituximab Plus Chemotherapy Followed by Obinutuzumab or Rituximab Maintenance in Patients With Untreated Advanced Indolent Non-Hodgkin's Lymphoma (GALLIUM)
2011-07-06
2021-07-30
Completed
1,401
A Study Comparing Maintenance Subcutaneous Rituximab With Observation Only in Participants With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma Who Had Responded to Rituximab-based Immunochemotherapy Induction and 2-year Maintenance With Subcutaneous Rituximab
2011-12-20
2018-06-02
Completed
692
TKI and Interferon Alpha Evaluation Initiated by the German Chronic Myeloid Leukemia Study Group - the TIGER Study
2012-08-24
2022-05-31
Completed
717
A Combination Study of Kadcyla (Trastuzumab Emtansine) and Capecitabine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer (mBC) or HER2-Positive Locally Advanced/Metastatic Gastric Cancer (LA/mGC)
2012-12-03
2017-05-31
Terminated
182
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Shimonoseki City Hospital" #1 sponsor was "Pfizer" with 3 trials, followed by "Janssen Research & Development, LLC" with 2 trials
sponsored, "Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan" with 2 trials sponsored, "Bayer" with 1 trials sponsored and "Janssen Pharmaceutical K.K."
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Shimonoseki City Hospital"
#1 collaborator was "Tokyo Medical and Dental University" with 2 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Shimonoseki City Hospital
According to Clinical.Site data, the most researched conditions in "Shimonoseki City Hospital" are
"Colorectal Cancer" (2 trials), "Low Back Pain" (2 trials), "Central Nervous System Diseases" (1 trials), "Chronic Cough" (1 trials) and "Diagnostic Imaging" (1 trials). Many other conditions were trialed in "Shimonoseki City Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Shimonoseki City Hospital
Most popular intervention types in "Shimonoseki City Hospital" are "Drug" (7 trials), "Biological" (4 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "UFT adjuvant chemotherapy" (2 trials), "Bedaquiline" (1 trials), "Celecoxib" (1 trials) and "Clarithromycin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Shimonoseki City Hospital
The vast majority of trials in "Shimonoseki City Hospital" are
10 trials for "All" genders.
Clinical Trials Status at Shimonoseki City Hospital
Currently, there are NaN active trials in "Shimonoseki City Hospital".
undefined are not yet recruiting,
2 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in Shimonoseki City Hospital,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Shimonoseki City Hospital, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".